Vesicant/Irritant Potential

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Thu, 06/29/2023 - 12:25
#1
Emily Messing
Emily Messing's picture
Offline
Last seen: 3 months 1 week ago
Joined: 02/22/2018 - 15:41
Vesicant/Irritant Potential

Our institution is looking to develop a process for regularly reviewing agents for vesicant or irritant potential when it is 1) FDA approved and 2) reported to FDA post market as having vesicant/irritant potential. Does your hospital have a committee or task force that manages/reviews this? Are there any specific resources that you use when reviewing this information? Any other information you can provide about your process would be greatly appreciated. Thank you!

Top